Continuing to chart its path forward post-pandemic, BioNTech struck a new deal Monday aimed at boosting its presence in oncology. The Covid-19 vaccine maker signed a collaboration with Germany’s Medigene, the companies announced, giving BioNTech […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that it received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne CDx to be used as a companion diagnostic to identify patients with Microsatellite Instability […]
The appointments come after Frank Clyburn left to run IFF and are part of broader executive turnover at Merck. Click here to view original post
DUBLIN: DUBLIN, Feb. 18, 2022 /PRNewswire/ — The "Global Adult Vaccine Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com’s offering. Adult Vaccine Market expected […]
Public Citizen has called out Pfizer. Again. The consumer advocacy nonprofit issued a statement Friday claiming the Big Pharma is building a patent wall by filing or intending to file patent applications in 61 countries, […]
DARMSTADT, Germany–(BUSINESS WIRE)–Merck, a leading science and technology company, today announced that the European Commission (EC) has approved once-daily oral TEPMETKO® (tepotinib) as monotherapy for the treatment of adult patients with advanced non-small cell lung […]
Three months after successfully fending off Teva’s proposed generic to its schizophrenia drug Invega Sustenna, Johnson & Johnson’s Janssen unit is back in court arguing another case of alleged patent infringement — this time from […]
Sanofi, Regeneron ditch Dupixent trial vs. Novartis and Roche’s Xolair for hives condition kdunleavy Fri, 02/18/2022 – 09:50 Click here to view original post
In a move that the company hopes will up its ability to respond to demand for its Covid-19 tests, Sorrento Therapeutics has acquired a majority ownership in a Chinese diagnostics manufacturer. Sorrento Therapeutics will use […]
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping […]
Copyright © 2022 Biotech Networks, LLC
